Mycobacterium tuberculosis complex test positive
(UMLS:C2748263)
- UMLS ID:
- C2748263
- MeSH ID:
- N/A
Synonym(s)
1.
Mycobacterium tuberculosis complex test positive
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | tofacitinib | FAERS: 109 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | apremilast | FAERS: 21 | US FAERS | |
| 3 | benzoylecgonine | FAERS: 10 | US FAERS | |
| 4 | Methotrexate | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | teriflunomide | FAERS: 8 | US FAERS | |
| 6 | Dimethyl Fumarate | FAERS: 5 | US FAERS | |
| 7 | Fingolimod Hydrochloride | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | 17 alpha-Hydroxyprogesterone Caproate | FAERS: 1 | US FAERS | |
| 9 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 10 | Bosentan | FAERS: 1 | US FAERS | |
| 11 | Finasteride | FAERS: 1 | US FAERS | |
| 12 | Gefitinib | FAERS: 1 | US FAERS | |
| 13 | Isotretinoin | FAERS: 1 | US FAERS | |
| 14 | Methotrexate | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 15 | Oseltamivir | FAERS: 1 | US FAERS | |
| 16 | PCI 32765 | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 17 | Ruxolitinib phosphate | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Tacrolimus | FAERS: 1 | US FAERS | |
| 19 | Testosterone | FAERS: 1 | US FAERS | |
| 20 | Triumeq | FAERS: 1 | US FAERS | |
| 21 | Vortioxetine | FAERS: 1 | US FAERS | |
| 22 | baricitinib | FAERS: 1 | US FAERS | |
| 23 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 24 | macitentan | FAERS: 1 | US FAERS | |
| 25 | midostaurin | FAERS: 1 | US FAERS | |
| 26 | pomalidomide | FAERS: 1 | US FAERS | |
| 27 | sapropterin | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.